Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease-Reference-Cited by-同舟云学术

Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease

Published:2021-10-11 Issue:1 Volume:42 Page:110-115
ISSN:0743-8346
Container-title:Journal of Perinatology
language:en
Short-container-title:J Perinatol

Author:

Rosenfeld Warren N.^ORCID,Hudak Mark L.^ORCID,Ruiz Nancy,Gautam Shiva,Alissa R.,Banfro F.,Barringham A.,Bettica L.,Bimbi R.,Brown A.,Camp L. G.,Chakraborty B.,Clark L.,Crawford S.,Dhanireddy R.,Eldemerdash A.,Fofah O.,Rhodes Ryan G.,Hanna N.,Hudak M.,Jewell A.,Katof N.,Kehinde F. D.,Kicklighter S.,Kim J.,Lowery V.,Maddox A.,Maduekwe E.,Meloy L.,Nason J.,Pollock K.,Reyes D.,Richter S.,Rosenfeld W.,Shafi N.,Shattuck K.,Smith P.,Stewart D.,Thomas M.,Wagner C.,Wong W.,

Funder

Funded by Infacare Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.nature.com/articles/s41372-021-01223-2.pdf

Reference36 articles.

1. Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S, et al. Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 2014;134:504–9.

2. Vanburg PK, Hansen BM, Greisen G, Mathiasen R, Kasper F, Ebbesen F, et al. Follow-up of extreme neonatal hyperbilirubinaemia in 5- to 10-year-old children: a Danish population-based study. Dev Med Child Neurol. 2015;57:378–84.

3. Amin SB, Saluja A, Saili A, Orlando M, Wang H, Laroia N, et al. Chronic auditory toxicity in late preterm and term infants with significant hyperbilirubinemia. Pediatrics. 2017;140:e20164009.